405 filings
Page 7 of 21
6-K
8s1orrx
11 Sep 18
Intellipharmaceutics Closes US$0.5 Million Convertible Debenture Financing
12:00am
424B3
y4q8u4i7tncpzh iq
11 Sep 18
Prospectus supplement
12:00am
424B3
m48zdrquo0g 2uuzzxg
15 Aug 18
Prospectus supplement
5:17pm
6-K
p9rz9u8h
15 Aug 18
Report of Voting Results
5:11pm
424B3
h81rrf7
9 Aug 18
Prospectus supplement
12:04pm
EFFECT
yqmi0hz4y72re0z eczj
9 Aug 18
Notice of effectiveness
12:15am
CORRESP
epy ktvyq4e
7 Aug 18
Correspondence with SEC
12:00am
F-1/A
ptr0kbayvjlc3qlzm015
3 Aug 18
Registration statement (foreign) (amended)
5:26pm
F-1/A
c34rfximn9pa23
3 Aug 18
Registration statement (foreign) (amended)
12:00am
6-K/A
3udg j4xu
24 Jul 18
Current report (foreign) (amended)
5:22pm
UPLOAD
rj84hf37
23 Jul 18
Letter from SEC
12:00am
F-1
nq9nijr4lm
18 Jul 18
Registration statement (foreign)
9:55pm
6-K
ow4lgp
16 Jul 18
Primary Document
5:06pm
6-K
supo30i xa8ke159qnk
13 Jul 18
Special Meeting of Shareholders
5:09pm
SC 13G
8fd0srxhxc2kgniewgi
11 Jun 18
Intellipharmaceutics International Inc.
4:43pm
6-K
dt06uzock
8 Jun 18
Intellipharmaceutics Receives Anticipated Additional Staff Determination Letter from Nasdaq
5:26pm
6-K
gqote0wy0umjba
22 May 18
Primary Document
4:08pm
6-K
lh4sldzjq7lvu2q a6y
16 May 18
Intellipharmaceutics Reports Director Election Results
8:05am
6-K
7fe9d
8 May 18
Intellipharmaceutics Announces Start of Intranasal Human Abuse
8:05am
6-K
3v8e2dfqbn1w3k
27 Apr 18
Primary Document
8:09am